I feel very lucky to have found this Company at this point. Friday it closed at my position average, having only been here a short time. I made purchases six times from 2.22 to 2.49, and now am set for what I see as a long term investment. The possibilities for this to impact lives on a world wide basis is daunting, with investors reaping a bounty as lives are changed. This has been easy for me to arrive late and see all this opportunity packed into a time warp of sorts, spring loaded, great management team, solid timeline of events set out front, and at such a low market cap, truly a blessing for investors to pile in now.
Your confidence in this Company and its trials is exemplary, you've done more research than almost anyone here, but Andre' was the first to put the bug in my ear, so he may have deeper DD? Maybe Techsmeck will surpass all? Thanks Ranger and Tech, all contributions appreciated.
Great news coverage George, this should spike the stock as we head into May and the next conference. I watched it twice, very exciting!,
You misrepresent what was covered in the video, and where are longs saying 100-200%? Lies.
Yes, yes, no, yes, that's my 2 cents. Anemic volume, no news, low morale matches trending lower price point, when action elsewhere spells lost opportunity.
Great point Ranger, like your thinking there. Has anyone noticed we have a pennant formation since the 15th on the hourly chart? Very bullish formation in my view. While this is a form of consolidation of our gains, it portends a breakout to the upside more often than not. What's it going to take, random trading on a good biotech day or news? Either way, that we are trading up today is a good sign in an otherwise sideways to down day.
Bought more today at 2.29, in last half hour, then it rallied into the close. Thank your team for driving the price down so us buyers could sweep in to accumulate on the lows of the last week. Now, get lost loser.
Looks like the curious run of the 3,824 'share buys' has come to an end, sadly. I also reviewed trades during the last 10 minutes but didn't find a lot of 3,824 shares. We likely won't ever know what this was all about, but the theories advanced here as to it being a coded message kept the entertainment value running for two weeks. 10 days = 38,240 shares, a decent position if I may add. GLAL.
I did just that today and added 1,600 shares at 2.29 15-20 minutes before the close. I was rewarded with a 6 cent equity in the closing minutes. After an intra-day reversal like today, this may lead to continuation tomorrow, for a resumption of the uptrend leading into next week's conference call. GLAL.
Are you always this negative, or didn't you notice the stock was up 12 cents AH? 91% of gaps fill, however, this is oversold now, not going to be oversold. Have a little perspective, we aren't going to get to your downside 3.37 target. Today was a higher low, a pronounced impulse higher low, how many stocks lose 24% in a day when an employee leaves, CEO is hired? We may trade around this level a few days, even go marginally lower, but recovery has already started as people get used to the changes.
Overstated, not happening, sector is climbing back, IBB and XBI are in improving quadrant and won't be long before XLV is back in leading quadrant together with these ETF's mentioned. I hold 9 biotechs, worst one is down 3% today. If you hold SRPT, you are hurting today but the sector isn't getting slaughtered.
Looking at my portfolio of 9 stocks, there is evidence everywhere of the short trade taking money out of the various market caps and our pockets. I have two stocks up, one flat, and 6 down. They are pulling even as little as two cents a day out of names like GALE. AVXL after a monster day two days ago, down .14. Will there ever be a day when we see these cockroaches fry and be squeezed hard? I get so tired of them wearing against these companies. Biotech must be their favorite sector due to high failure rate of trials and the dearth of news flow.
April 26th, stock down 3 cents to 1.30. It's clear April wasn't our month to break out of this very controlled price range. May should be better, good luck all longs.
Call to Action for Participation in Clinical Trials is Topic of Symposium at Alzheimer's Disease International Conference 2016
Event Featuring Marc Wortmann of ADI and Professor Dr. Harald Hampel to be Streamed Live on the Web
PR Newswire Axovant Sciences Ltd.
April 19, 2016 7:30 AM
HAMILTON, Bermuda, April 19, 2016 /PRNewswire/ -- Axovant Sciences Ltd. (AXON) today announced it is sponsoring a symposium at the Alzheimer's Disease International Conference 2016: "Alzheimer's Community Call to Action: Developing New Treatments Through Clinical Trial Participation."
Here's what Harold had to say (he's an esteemed member of our scientific advisory board at Anavex):
"No new chemical entity has been approved for treatment of Alzheimer's disease in over a decade, but there are several potential treatments in the final stages of clinical development," said Dr. Hampel. "I look forward to sharing more information about the latest research trends, and the important role patients and caregivers play in contributing to this research."
"Too often, people with dementia and their caregivers may not be aware of clinical trial opportunities available to them, or the importance of participation," said Mr. Wortmann. "I look forward to sharing information on what Alzheimer's associations can do to help educate their members about these opportunities."
That was it, of course, MM waited for a quiet day, caught me by surprise. There's an interesting post over on the Sage YMB, by a basher, can't say that his point may not have merit:
joe120055 • Mar 25, 2016 12:54 PM Flag
1users liked this postsusers disliked this posts2Reply
The Cambridge based VC firms have been running a profitable Ponzi scheme for years now. Sage is just one of the latest installments. By now, it is a well-oiled machine and goes something like this:
I found it interesting, if you do, go there and read the thread, too long to re-post here. As I type this, we are trading at 5.70 having briefly eclipsed 5.80 on the way back up from 5.55.
And thank you for a comprehensive well written article. Love your handle here, reflects well on your expertise, now confirmed with the article. Keep up the good work, we appreciate it. I keep adding, twice this week, as low as 2.29 and again today at 2.36 after reading your article.
Sentiment: Strong Buy